The Esquire article has shown another problem that couples with what you mentioned N2K, the powerful groups that are keeping ADFs off the market.
The Sacklers are just one group of such people.
Without ADFs on the market these powerful groups continue to rake in major dough. Maybe there is also the political aspect of major campaign contributions from Big Pharms much like the NRA and the gun lobby.
The similarities to other industries such as big tobacco and the NRA are very striking and very real.
McKesson, Purdue, J&J, and others stand to lose big markets to ADF alternatives which in turn would cost those companies major money and time to develop on their own. Meanwhile a little company like Elite sits here with a key ADF technology.
N2K, you have been saying this for a long time, a buyout will come, and I have no doubt that it will. It almost has to. There may be a several suitors for Elite in the near future. Would not be surprised if Elite is in a bidding war between other Big Pharmas when a buyout comes. Who controls the ADF aspect of this sector will have control over market share. Just my opinion.
News 
Market Data 
Discover 
